{"version":"1.0","provider_name":"Pharma Trend","provider_url":"https:\/\/pharma-trend.com\/en","author_name":"Business Wire","author_url":"https:\/\/pharma-trend.com\/en\/author\/business\/","title":"ObjectiveHealth Announces 30th Research Center of Excellence - Pharma Trend","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"vbPA0IxEc9\"><a href=\"https:\/\/pharma-trend.com\/en\/objectivehealth-announces-30th-research-center-of-excellence\/\">ObjectiveHealth Announces 30th Research Center of Excellence<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/pharma-trend.com\/en\/objectivehealth-announces-30th-research-center-of-excellence\/embed\/#?secret=vbPA0IxEc9\" width=\"600\" height=\"338\" title=\"&#8220;ObjectiveHealth Announces 30th Research Center of Excellence&#8221; &#8212; Pharma Trend\" data-secret=\"vbPA0IxEc9\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/pharma-trend.com\/en\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"Nashville-based research and technology company currently has active research centers in 16 states across the country NASHVILLE, Tenn.&#8211;(BUSINESS WIRE)&#8211;#amarillo&#8212;ObjectiveHealth, a Nashville-based integrated research and technology platform company, today announced the opening of its 30th research site, Amarillo Premier Research, in Amarillo, Texas. Since establishing its first research center in Nashville in 2018, ObjectiveHealth has expanded ... [Read more...]","thumbnail_url":"https:\/\/mms.businesswire.com\/media\/20230411005109\/en\/1759116\/21\/ObjectiveHealth_logo_tag_RGB.jpg"}